Cytomics Pharmaceuticals
Orsay
About Cytomics Pharmaceuticals
Cytomics Systems is a French private company that offers bio-pharmacology services. The company uses Yeast Micro-Lab technology, a protenomics tool, which enables to follow in-vitro deterioration of proteins. Cytomics Systems's research and development focuses on fungicidal infections, inflammatory illnesses, and cancers. Cytomics Systems, S.A was founded in 2000 and is based in Gif-sur-Yvette, France.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $11.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2006)
- Website: cytomics.fr
- Phone: +33 1 69 82 42 80
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cytomics-pharmaceuticals-2840927 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.